Podcasts about md phd

Follow Michael Nehls, MD, PhD https://twitter.com/NehlsMD https://michael-nehls.com   Michael Nehls' Book: The Indoctrinated Brain https://www.skyhorsepublishing.com/9781510778368/the-indoctrinated-brain/   We The People must stand strong, stay united, resolute, calm and focus on the mission - God Wins!   We at www.themelkshow.com want to thank all our amazing patriots pals for joining us on this journey, for your support of our work and for your faith in this biblical transition to greatness. We love what we do and are working hard to keep on top of everything to help this transition along peacefully and with love. Please help us amplify our message: Like, Comment & Share!   The Show's Partners Page: https://themelkshow.com/partners/ Consider Making A Donation: https://themelkshow.com/donate/   Another way to get involved and find ways to become active in the community is to come meet Mel and many amazing truth warriors at our upcoming live in person speaking events. Together we are unstoppable. We look forward to seeing you. God Wins! https://themelkshow.com/events/   ReAwaken America Tour Tulare, CA - Dec 15 & 13   For ReAwaken America events, use code “MELK” to enter for a chance to win VIP passes and one-on-one meet-and-greets with Mel K and Eric Trump!   Remember to mention Mel K for great discounts on all these fun and informative events. See you there! Our Website www.TheMelKShow.com   Rumble (Video) - The Mel K Show: https://rumble.com/c/TheMelKShow Twitter: https://twitter.com/MelKShow Twitter (Original): https://twitter.com/originalmelk TRUTH Social: https://truthsocial.com/@themelkshow Instagram: https://www.instagram.com/themelkshow/ CloutHub: https://app.clouthub.com/#/users/u/TheMelKShow Mel K Show Video Platform (Subscription): https://www.themelkshow.tv Bitchute: https://www.bitchute.com/channel/Iw2kiviwZpwx/ Podbean: https://themelkshow.podbean.com/ Gab: https://gab.com/MelKShow GETTR: https://www.gettr.com/user/themelkshow Locals.com: https://melk.locals.com/ Telegram - The Mel K Show Group: https://t.me/themelkshowgroup Banned Video: https://banned.video/channel/the-mel-k-show Brighteon: https://www.brighteon.com/channels/themelkshow Odysee: https://odysee.com/@themelkshow:5   If you are interested to explore investing in precious metals please contact below and mention MelK for special offers:   Beverly Hills Precious Metals Exchange Buy Gold & Silver https://themelkshow.com/gold/ Speak with Gold Expert Andrew Sorchini…Tell Him Mel K Sent You!   Support Patriots With MyPillow Go to https://www.mypillow.com/melk Use offer code “MelK” to support both MyPillow and The Mel K Show   Mel K Superfoods Supercharge your wellness with Mel K Superfoods Use Code: MELKWELLNESS and Save Over $100 off retail today! www.MelKSuperfoods.com   Patriot Mobile Support your values, your freedom and the Mel K Show. Switch to Patriot Mobile for Free. Use free activation code MELK https://www.patriotmobile.com/melk/   HempWorx The #1 selling CBD brand. Offering cutting edge products that run the gamut from CBD oils and other hemp products to essential oils in our Mantra Brand, MDC Daily Sprays which are Vitamin and Herb combination sprays/ https://themelkshow.com/my-daily-choice/   Dr. Zelenko Immunity Protocols https://zstacklife.com/MelK   Dr. Jason Dean and BraveTV bring you the most innovative and cutting edge science in Nutrition with Nano-Particle Detoxification, The Full Moon Parasite Protocol and Clot Shot Defense. https://bravetv.store/?sca_ref=3278505.GWvLbyryzv   Dr. Stella Immanuel, MD. Consult with a renowned healthcare provider! Offering Telehealth Services & Supplements. Use offer code ‘MelK' for 5% Off https://bit.ly/MelKDrStellaMD  

Dave declared this recording day to be “Effort Free Friday,” as it was officially Thanksgiving Break! That didn't stop M1 Jeff Goddard from describing a recent meeting of the AMA Students Section that offered an object lesson on how policy is (or in this case, isn't) made. Among many other topics, some students wanted the AMA to declare a position on the current Israel-Hamas war. In the end, the AMA declined to do so, perhaps deciding that it didn't have the political capital on a divisive issue that could threaten its ability to participate in other conversations it has a more direct role in. Co-hosts M2 Happy Kumar, MD/PhD student Faith Goddard, and MD/PhD student Riley Behan Bush talk about their personal efforts to understand this compilated issue. And, In the spirit of the tenets of Effort Free Friday, Dave dragged Alex Trebot out from the AI closet to host a trivia contest.

Krissy Dilger of SRNA was joined by Drs. Drs. John J. Chen and Elias S. Sotirchos for an “Ask the Expert” podcast episode titled “Acute Treatments and Rare Neuroimmune Disorders.” The experts began by providing an overview of treatments for an acute demyelinating attack and how they are administered. They also discussed side effects, safety concerns, and the decision process for escalation. Finally, the experts shared age considerations and upcoming research. John Chen, MD, PhD attended the University of Virginia for his undergraduate and combined MD/PhD degrees. He completed his Ophthalmology residency and Neuro-Ophthalmology fellowship training at the University of Iowa. He then took a position at the Mayo Clinic in 2014 where he specializes in Neuro-Ophthalmology. Currently, he serves as a Consultant and Professor of Ophthalmology and Neurology, and Neuro-Ophthalmology Fellowship Director at the Mayo Clinic. Among Dr. Chen's awards/honors are the AAO Achievement Award, resident and fellow teaching awards at the University of Iowa, Ophthalmology Teacher of the Year Award three times at the Mayo Clinic, 2023 Mayo Clinic Distinguished Educator Award, Top Doctors in Minnesota, and the Heed Fellowship. He is a board member for the North American Neuro-Ophthalmology Society and is on multiple committees for the AAO, co-chairs the Upper Midwest Neuro-Ophthalmology Group, is a member of the American Ophthalmological Society and American Eye Study Club, previously served as the President for the Minnesota Academy of Ophthalmology and participated in the AAO and AUPO Leadership Development Programs. He has over 200 peer-reviewed publications, has received several research awards, and is currently RO1 funded through the NIH. He has given over 200 oral presentations, including multiple named lectureships, and visiting professorships, on his interests in ophthalmic imaging, idiopathic intracranial hypertension, and optic neuritis, especially NMOSD and MOG antibody-associated disease. Elias Sotirchos, MD is a neurologist at Johns Hopkins Hospital in Baltimore, Maryland. He specializes in the diagnosis, management, and treatment of neuroimmunological disorders that involve the central nervous system, including multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), and myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG)-associated disorder (MOGAD). His research focuses on developing and validating novel imaging and blood-based biomarkers of these conditions, and clinical trials of experimental therapeutic agents.

This video features Dr. Juan Carlos Lopez-Delgado, Professor of Critical and Emergency Care at the University of Barcelona. Dr. Lopez-Delgado's journey to nutrition was not a straight path. He began his career in general critical care and developed an interest in nutrition after spending time as a resident in England, sparking his passion for metabolism and the liver. As a researcher in muscle metabolism, Dr. Lopez-Delgado shares that the use of Bioelectrical Impedance Analysis (BIA) during the pandemic helped his team identify how important muscle mass is in relation to mortality. He continues research today in this area with the use of BIA. Dr. Lopez-Delgado also emphasizes the importance of mentorship, noting how members from the physician engagement committee have helped to mentor and challenge him in his career. He encourages clinicians to make friends along the way and be a good person. Dr. Lopez-Delgado likes to spend his free time with his wife and 2 sons, especially watching fútbol. Physician Spotlight is a forum for outstanding Senior Leaders, Young Rising Stars, and International Colleagues in the field of nutrition to discuss important topics and ideas that impact patient care. Visit the ASPEN Physician Community at www.nutritioncare.org/physicians

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/UDJ865. CME credit will be available until November 20, 2024.Honing Diagnostic and Management Skills: The Role of the Pediatrician in the New Era of Rett Syndrome Management In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from ACADIA Pharmaceuticals Inc.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresChair/PlannerEric Marsh, MD, PhD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Acadia Pharmaceuticals Inc. and Stoke Therapeutics.Grant/Research Support from Acadia Pharmaceuticals Inc.; Curaleaf, Inc.; Epygenix Therapeutics, Inc.; Marinus Pharmaceuticals, Inc.; Stoke Therapeutics; and Takeda Pharmaceutical Company Limited.Faculty/PlannerDavid N. Lieberman, MD, PhD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Acadia Pharmaceuticals Inc.; Anavex Life Sciences Corp.; Neurogene Inc.; and Taysha Gene Therapies, Inc.Grant/Research Support from Acadia Pharmaceuticals Inc.; Anavex Life Sciences Corp.; and Jazz Pharmaceuticals, Inc.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/UDJ865. CME credit will be available until November 20, 2024.Honing Diagnostic and Management Skills: The Role of the Pediatrician in the New Era of Rett Syndrome Management In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from ACADIA Pharmaceuticals Inc.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresChair/PlannerEric Marsh, MD, PhD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Acadia Pharmaceuticals Inc. and Stoke Therapeutics.Grant/Research Support from Acadia Pharmaceuticals Inc.; Curaleaf, Inc.; Epygenix Therapeutics, Inc.; Marinus Pharmaceuticals, Inc.; Stoke Therapeutics; and Takeda Pharmaceutical Company Limited.Faculty/PlannerDavid N. Lieberman, MD, PhD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Acadia Pharmaceuticals Inc.; Anavex Life Sciences Corp.; Neurogene Inc.; and Taysha Gene Therapies, Inc.Grant/Research Support from Acadia Pharmaceuticals Inc.; Anavex Life Sciences Corp.; and Jazz Pharmaceuticals, Inc.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

Ana Rosa, MD, PhD is a physician, Radiologist, Body fellowship trained, alumni of the University of Minnesota, medical doctor at the VA healthcare system, and assistant professor at the University of Minnesota. Dr. Rosa has done two radiology residencies, one in Brazil, and one in the United States, obtained a doctorate degree, had done a body imaging fellowship, and also has published in medical journals and helped writing Imaging books in Brazil with 25 years of practice in the Imaging field as a Radiologist. Dr. Rosa shares with us her imaging knowledge of visceral fat, the importance of its detection and description in the reports, guiding the patients and the ordering providers by the findings on cross-section imaging such as MRI scans.  The podcast intention is to bring awareness on how to detect a simple and easy biomarker such as visceral fat on MRI scans making it easier for patients to advocate for health and follow up for results. Dr. Rosa shares with us how to create quality of care in service for education and interaction between patients, providers and Radiologists in sharing her own story on how to heal from inside out by literally “seeing” a “silent” metabolic active killer that visceral fat represents and taking action to change the presence status quo And move towards optimizing health.     SHOW NOTES (06:37) In medical school, healthcare professionals are trained to describe diseases while overlooking how visceral fat and metabolic health contributes to them. (15:52) Visceral fat is a major culprit when it comes to various metabolic issues. (28:04) The first step to prevent disease is to look for signs of inflammation. (31:17) While it's possible to request your MRI scan from your doctor, most providers won't know how to make use of it. (44:02) Health is not limited to staying alive. Health is also appearance and performance. (53:58) For doctors, another benefit of learning to deal with patients carrying high amounts of visceral fat is potentially minimizing burnout.

Episode #288. Discover the truth about the canola oil debate with Dr Gil Carvalho. A respected physician and research scientist, Dr Carvalho unpacks the complexities of canola oil's role in our health. With no ties to industry, his unbiased perspective sheds light on how canola oil affects our bodies, its comparison to other oils, and the science behind the headlines. Tune in for a candid conversation that promises to enhance your understanding help you make informed dietary decisions. Specifically, we discuss: Introduction (00:00) What Inspired the Canola Oil Video (01:58) Defining Canola Oil: Origins and Composition (06:35) The Most Common Claims About Canola Oil (12:13) Research Methodology in Canola Oil Investigation (17:45) The Significance of Human Data in Canola Oil Research (22:48) Understanding Meta-analysis Studies and Epidemiological Approaches (26:37) Assessing the Adequacy of Canola Oil Research (42:07) Canola Oil's Impact on Blood Lipids and Cardiovascular Health (46:20) Canola Oil vs. Nuts and Seeds for Weight Loss (50:36) Canola Oil Consumption and the Risk of Heart Attack/Stroke (56:48) Canola Oil and Blood Glucose Control (1:00:57) Canola Oil's Influence on Body Weight (1:04:29) Is Canola Oil Inflammatory? (1:08:54) Examining the "Wash-IN-DIET Canola Oil" Study by Junker R and Kratz M (1:11:24) Lipid Peroxidation: Canola Oil Oxidation (1:14:44) Research on Liver Fat and Canola Oil (1:21:50) Linoleic Acid Consumption and Total Mortality (1:23:10) Reception of the Canola Oil Video within the NutritionMadeSimple Community (1:25:59) Addressing Common Questions About Canola Oil (1:33:02) Assessing Research Funding from the Canola Industry (1:37:19) Making the Case for Canola Oil Toxicity (1:40:19) Is Canola Oil Classified as an Ultra-Processed Food? (1:42:48) Future Studies Required for a Comprehensive Understanding of Canola Oil and Human Health (1:46:50) Conclusion (1:48:07) You can learn more about Dr Gil Carvalho here, and connect with him on Twitter/X and Facebook. For straightforward, science-based nutrition information, visit his YouTube channel Nutrition Made Simple. You can also access his research publications for more. Optimise your health with InsideTracker's biomarker analysis. Get exclusive access to InsideTracker's new ApoB test and a 20% discount on your first order at insidetracker.com/simon. Enjoy, friends. Simon Want to support the show? The best way to support the show is to use the products and services offered by our sponsors. To check them out, and enjoy great savings, visit theproof.com/friends. You can also show your support by leaving a review on the Apple Podcast app and/or sharing your favourite episodes with your friends and family. Simon Hill, MSc, BSc (Hons) Creator of theproof.com and host of The Proof with Simon Hill Author of The Proof is in the Plants Watch the episodes on YouTube or listen on Apple/Spotify Connect with me on Instagram, Twitter, and Facebook Nourish your gut with my Plant-Based Ferments Guide Download my complimentary Two-Week Meal Plan and high protein Plant Performance recipe book

Karim Fizazi, MD, PhD - The Science and the Art of Modern Prostate Cancer Care: Improving Patient Outcomes Through Intensification and Individualisation of Treatment

Karim Fizazi, MD, PhD - The Science and the Art of Modern Prostate Cancer Care: Improving Patient Outcomes Through Intensification and Individualisation of Treatment

Karim Fizazi, MD, PhD - The Science and the Art of Modern Prostate Cancer Care: Improving Patient Outcomes Through Intensification and Individualisation of Treatment

Karim Fizazi, MD, PhD - The Science and the Art of Modern Prostate Cancer Care: Improving Patient Outcomes Through Intensification and Individualisation of Treatment

The AMA Joy in Medicine™ Health System Recognition Program has recognized Ochsner Health for the third time in 2023. Nigel Girgrah, MD, PhD, chief wellness officer at Ochsner Health joins to discuss the evolution of Ochsner's organizational well-being program and its strategic framework for the future. American Medical Association CXO Todd Unger hosts.

On November 9, 2023 we talked to Anne West about promoters, transcription factors and histones for controlling gene expression in neurons during development and adulthood. Guest: Anne West, Professor of Neurobiology and Cell Biology, Duke University Participating, Alexey Soshnev, Department of Neuroscience, Developmental and Developmental Biology, UTSA Host: Charles Wilson, Department of Neuroscience, Developmental and Developmental Biology, UTSA Thanks to JM Tepper for original music

In the last few years we have witnessed the rise of very resistant fungal species some of them likely influenced by environmental conditions and climate change. Fortunately, there has been a bit of an explosion in the development of new antifungals and the pipeline has been strengthened in the last decade. We will have the ability to have new molecules with distinct and novel mechanisms of action in the near future that may contribute to combat recalcitrant fungal infections. Topics discussed: The overall threat of fungal resistance. The antifungal pipeline in the last few years. New promising antifungals Guests: Andreas Groll, MD PhD, Professor of Pediatrics, Head of the Infectious Disease Research Programme and Deputy Director of the Department of Haematology/Oncology at the University Children's Hospital in Münster, Germany. Editor AAC This episode of Editors in Conversation is brought to you by the Antimicrobial Agents and Chemotherapy Journal and hosted by AAC Editor in Chief, Cesar Arias.  AAC is available at https://asm.org/aac.  Follow Cesar on twitter at https://twitter.com/SuperBugDoc for AAC updates.  Subscribe to the podcast at https://asm.org/eic

Andreas Kremer, MD, PhD, MHBA - Incorporating the Investigation of Itch Into the Patient Care Process for PBC: Practical Steps, Tips, and Tools

AOA President Ann Van Heest, MD, FAOA, connected with Canadian Orthopaedic Association (COA) Past President, Laurie Hiemstra, MD, PhD, FRCSC, to discuss her unusual path to leadership, her plan for improving diversity in orthopaedics, and the most pressing critical issues affecting the COA. While waitlisting and licensure issues between provinces continue to be a challenge within the orthopaedic specialty, Dr. Hiemstra made it her goal to advocate for underrepresented groups, unify the community, and help develop competent young orthopaedic leaders. 

The Emergency Department is perhaps the singular environment in a hospital where the greatest concentration of decisions are made with the least amount of clinical data; and the acuity-level assigned at triage can massively impact the trajectory of care for apatient. Additionally, Emergency Departments in the United States have experiencedunprecedented levels of crowding over the last two decades, with correlation to worsened patient outcomes, preventable errors, and staff burnout.In 2017, the ED at Johns Hopkins deployed a CDS tool that leverages AI to generaterisk-driven triage acuity recommendations, instead of relying on resource-based ESI. The tool has provided more reliable detection of patients with critical illness and reduced the time patients wait for care. They've also seen marked decrease in those assigned to the mid-acuity level 3, and instead more utilization of the low-acuity levels 4 and 5, which lends to better fast-track throughput for those patients who are to be discharged.Jeremiah Hinson, MD PhD, will speak of his experience developing and utilizing the toolwith his team at Johns Hopkins.

In this episode of Life Science Success, my guest is Todd Druley PhD.  Todd is the Chief Medical Officer at Mission Bio.  His expertise lies in translational genomic and computational tools to improve clinical diagnostics and apply these tools to disease-specific questions in cancer.   Key Takeaways: Dr. Todd Druley is the Chief Medical Officer at Mission Bio, specializing in translational genomics and computational tools for clinical diagnostics, especially in cancer. Dr. Druley's career was influenced by a personal connection to pediatric leukemia, leading him to bridge medicine and genomics research. He transitioned from academia to industry, joining companies like Archer DX and Mission Bio to have a broader impact in diagnostics and treatment. Dr. Druley emphasizes the importance of single-cell multiomics in diagnostics and bridging the gap between technical advancements and clinical treatments in pediatric oncology.  

Go online to PeerView.com/HHW860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Despite all of the advances in cancer treatment, there is still a significant need for a fourth pillar of therapy that can help improve outcomes for patients across a spectrum of solid tumors, such as glioblastoma, lung cancer, and GI malignancies. In this PeerView activity, an expert faculty panel will review the latest cutting-edge data supporting the use of tumor treating fields (TTFields) and synergistic combination strategies in established and emerging solid tumor indications from CNS to thoracic malignancies and beyond. You'll gain strategies to maximize treatment adherence and quality of life, develop skills for evidence-based adverse event management, and discover life-prolonging clinical trial opportunities. Delve into the science behind the use of TTFields in the treatment of solid malignancies, the latest evidence on the efficacy and safety of this modality across approved and emerging indications, and radiation oncology–focused guidance for the safe and effective incorporation of TTFields therapy in the clinic. Upon completion of this activity, participants should be better able to: Describe the mechanistic rationale and evidence supporting the use of TTFields for the treatment of patients with CNS, thoracic, and other aggressive solid tumors; Integrate TTFields into multimodal management protocols for appropriately selected patients with CNS, thoracic, and other solid malignancies; and Devise team-based strategies designed to mitigate and manage adverse events associated with TTFields to improve outcomes in patients with difficult-to-treat cancers.

Go online to PeerView.com/HHW860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Despite all of the advances in cancer treatment, there is still a significant need for a fourth pillar of therapy that can help improve outcomes for patients across a spectrum of solid tumors, such as glioblastoma, lung cancer, and GI malignancies. In this PeerView activity, an expert faculty panel will review the latest cutting-edge data supporting the use of tumor treating fields (TTFields) and synergistic combination strategies in established and emerging solid tumor indications from CNS to thoracic malignancies and beyond. You'll gain strategies to maximize treatment adherence and quality of life, develop skills for evidence-based adverse event management, and discover life-prolonging clinical trial opportunities. Delve into the science behind the use of TTFields in the treatment of solid malignancies, the latest evidence on the efficacy and safety of this modality across approved and emerging indications, and radiation oncology–focused guidance for the safe and effective incorporation of TTFields therapy in the clinic. Upon completion of this activity, participants should be better able to: Describe the mechanistic rationale and evidence supporting the use of TTFields for the treatment of patients with CNS, thoracic, and other aggressive solid tumors; Integrate TTFields into multimodal management protocols for appropriately selected patients with CNS, thoracic, and other solid malignancies; and Devise team-based strategies designed to mitigate and manage adverse events associated with TTFields to improve outcomes in patients with difficult-to-treat cancers.

Go online to PeerView.com/BJF860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Eosinophilic esophagitis (EoE) is a chronic allergic type 2 inflammatory disease that is triggered by food and/or environmental allergens. It is characterized by a clinical and pathologic phenotype of progressive esophageal dysfunction due to tissue inflammation and fibrosis. EoE affects about 1 in 2,000 people in the United States, and its prevalence is increasing. Until recently, there were no FDA-approved therapies, and management was limited to dietary approaches, drugs such as proton pump inhibitors and topical corticosteroids, and esophageal dilation. Targeted biologic therapies, some of which are already approved for other type 2 inflammatory disorders, are now available or are in development for the treatment of EoE. A recent PeerView live event helped to prepare clinicians to appropriately use these agents and offered a patient perspective on disease burden, the disconnect between symptoms and disease activity, and the need for continuous monitoring and maintenance treatment. The expert faculty offered recommendations for pediatric patient populations and told the “Story Behind the Science,” adding meaning to the data. If you couldn't attend the live event, check out this on-demand version now! Upon completion of this activity, participants should be better able to: Discuss the burden of eosinophilic esophagitis (EoE) on patient/caregiver quality of life, the progressive nature of the disease, and the need for continuous monitoring and treatment, thereby improving the standard of care; Recognize the role of underlying type 2 inflammation in the development and progression of EoE and describe the rationale for targeted treatment, particularly when type 2 comorbidities are present; and Employ the latest expert recommendations and clinical evidence to treat patients with EoE, including pediatric populations, using a shared decision-making approach.

Go online to PeerView.com/BJF860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Eosinophilic esophagitis (EoE) is a chronic allergic type 2 inflammatory disease that is triggered by food and/or environmental allergens. It is characterized by a clinical and pathologic phenotype of progressive esophageal dysfunction due to tissue inflammation and fibrosis. EoE affects about 1 in 2,000 people in the United States, and its prevalence is increasing. Until recently, there were no FDA-approved therapies, and management was limited to dietary approaches, drugs such as proton pump inhibitors and topical corticosteroids, and esophageal dilation. Targeted biologic therapies, some of which are already approved for other type 2 inflammatory disorders, are now available or are in development for the treatment of EoE. A recent PeerView live event helped to prepare clinicians to appropriately use these agents and offered a patient perspective on disease burden, the disconnect between symptoms and disease activity, and the need for continuous monitoring and maintenance treatment. The expert faculty offered recommendations for pediatric patient populations and told the “Story Behind the Science,” adding meaning to the data. If you couldn't attend the live event, check out this on-demand version now! Upon completion of this activity, participants should be better able to: Discuss the burden of eosinophilic esophagitis (EoE) on patient/caregiver quality of life, the progressive nature of the disease, and the need for continuous monitoring and treatment, thereby improving the standard of care; Recognize the role of underlying type 2 inflammation in the development and progression of EoE and describe the rationale for targeted treatment, particularly when type 2 comorbidities are present; and Employ the latest expert recommendations and clinical evidence to treat patients with EoE, including pediatric populations, using a shared decision-making approach.

Last week was along with STAW, World Sleep 2023 was also celebrated. The SleepTech Talk crew talk to Lourdes Delrosso, MD PhD about the World Sleep Society and World Sleep 2023 in Brazil. You can find Dr Delrosso on LinkedIn and learn more about World Sleep at https://worldsleepsociety.org/ Please support our sponsors: React Health https://www.reacthealth.com Medbridge Healthcare: For Job Opportunities with MedBridge Healthcare click here: https://medbridgehealthcare.com/careers/ Don't forget to Like, Share, Comment, and Subscribe! Learn more about the show on https://www.sleeptechtalk.com/ Credits: Audio/ Video: Diego R Mann; Music: Pierce G Mann Hosts: J. Emerson Kerr, Robert Miller, Gerald George Mannikarote Copyright: ⓒ 2023 SleepTech Talk Productions

Paolo Sbraccia, MD, PhD - Providing State of the Art Care for People With Obesity: Can We Break Free From the Status Quo?

Paolo Sbraccia, MD, PhD - Providing State of the Art Care for People With Obesity: Can We Break Free From the Status Quo?

Paolo Sbraccia, MD, PhD - Providing State of the Art Care for People With Obesity: Can We Break Free From the Status Quo?

“I think brutal focus is the key. So, you know, often when we start to think about a performance, one of the biggest questions people come and talk to me about is like, Oh, I'm trying to do so much. I have no time. I'm trying to figure out how to fit it all in. And I think it's really interesting that when we think about performance, we often approach the problem from the standpoint of how do I do more? How do I, you know, create more time to work harder. And so, I think one of my most important tips about this is to actually start from the premise that you will absolutely not do it all.”   Carla Fowlers Top Five Tips For Pursuing High Performance In Your Life1. Don't do it all.2. Make your results visible.3. You will often have to go before you know everything.4. A dream is not enough.5. Knowing does not equal doing TIME STAMP SUMMARY 01:56 Breathe, don't try to be superman.06:09 How to prioritize and decide what is important.13:18 Having to go before you know everything.21:51 Just keep going. Where to find Carla?Website                               http://www.thaxa.com/LinkedIn                               https://www.linkedin.com/in/carla-fowler Carla Fowler Bio Carla Fowler, MD PhD founded THAXA out of a passion for performance science, where the fields of strategy, productivity, and psychology intersect. Since its inception in 2013, THAXA's scientific approach to individualized coaching has attracted a devoted client base of dozens of executives at firms ranging from Fortune 500 technology companies to venture-backed startups to innovative non-profits. Carla's coaching methods draw upon the multidisciplinary field of performance science to generate the best ideas surrounding strategy, execution, and mindset to assist leaders in their endeavours. Over the past 10 years, she has distilled the key principles of performance into understandable concepts and a method that helps leaders incorporate these ideas into their day-to-day performance, helping them go faster and improving their results. Outside of her coaching, Carla truly enjoys sharing her key performance principles with audiences while engaging in thought-provoking conversations surrounding her passion for performance science. Carla graduated from Brown University magna cum laude, earned her MD and PhD at the University of Washington, and completed her internship in general surgery at Stanford University. She has also competed in athletics at the elite level for many years, winning a world championship and three national titles in the sport of Ultimate Frisbee.

When I first discovered Synapse Medicine, I was fascinated by the depth of work they had done to handle prescriptions and clinical decision support in their system.  Since their system was and is being broadly used in France, they were able to see and work on all the problems associated with medication management and discover the solutions that worked across a wide swath of patients and environments.  Needless to say, there's more to prescription management and medication decision support than you would expect at first glance. This is why I was excited to sit down with Clement Goehrs, MD-PhD, CEO & Co-Founder Synapse Medicine, to learn more about these topics and Synapse Medicine's progress bringing these solutions to the US market and other countries.  We kick off our discussion around prescription safety and Goehrs offers a nice framework for thinking about prescription safety including two macro trends that are making medication management more challenging: Changing Demographics (Older Population) and Advancement in Treatment Options. Learn more about Synapse Medicine: https://synapse-medicine.com/ Health IT Community: https://www.healthcareittoday.com/

Go online to PeerView.com/VWR860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Due to the rarity of Rett syndrome and overlapping symptoms with other, more common neurodevelopmental disorders, diagnosis is challenging and often missed or delayed. With one Rett-targeted therapy recently approved and others in development, clinicians now have the opportunity to offer not merely symptom management but potential clinical improvement. This PeerView case-based activity is designed to improve your ability to recognize, diagnose, and treat patients with Rett syndrome. Each session features a realistic case discussion with expert faculty panelists sharing the evidence that supports clinical decisions for timely diagnosis and early initiation of multidisciplinary management and targeted therapy as appropriate. Upon completion of this activity, participants should be better able to: Apply diagnostic criteria to provide a timely diagnosis of Rett syndrome in patients demonstrating subtle signs and symptoms; Employ evidence-based, age-appropriate care for patients with Rett syndrome in alignment with consensus management guidelines; and Evaluate the evidence surrounding the safety, efficacy, and tolerability of new and emerging therapies for the treatment of Rett syndrome.

Go online to PeerView.com/VWR860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Due to the rarity of Rett syndrome and overlapping symptoms with other, more common neurodevelopmental disorders, diagnosis is challenging and often missed or delayed. With one Rett-targeted therapy recently approved and others in development, clinicians now have the opportunity to offer not merely symptom management but potential clinical improvement. This PeerView case-based activity is designed to improve your ability to recognize, diagnose, and treat patients with Rett syndrome. Each session features a realistic case discussion with expert faculty panelists sharing the evidence that supports clinical decisions for timely diagnosis and early initiation of multidisciplinary management and targeted therapy as appropriate. Upon completion of this activity, participants should be better able to: Apply diagnostic criteria to provide a timely diagnosis of Rett syndrome in patients demonstrating subtle signs and symptoms; Employ evidence-based, age-appropriate care for patients with Rett syndrome in alignment with consensus management guidelines; and Evaluate the evidence surrounding the safety, efficacy, and tolerability of new and emerging therapies for the treatment of Rett syndrome.

Go online to PeerView.com/VWR860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Due to the rarity of Rett syndrome and overlapping symptoms with other, more common neurodevelopmental disorders, diagnosis is challenging and often missed or delayed. With one Rett-targeted therapy recently approved and others in development, clinicians now have the opportunity to offer not merely symptom management but potential clinical improvement. This PeerView case-based activity is designed to improve your ability to recognize, diagnose, and treat patients with Rett syndrome. Each session features a realistic case discussion with expert faculty panelists sharing the evidence that supports clinical decisions for timely diagnosis and early initiation of multidisciplinary management and targeted therapy as appropriate. Upon completion of this activity, participants should be better able to: Apply diagnostic criteria to provide a timely diagnosis of Rett syndrome in patients demonstrating subtle signs and symptoms; Employ evidence-based, age-appropriate care for patients with Rett syndrome in alignment with consensus management guidelines; and Evaluate the evidence surrounding the safety, efficacy, and tolerability of new and emerging therapies for the treatment of Rett syndrome.

Go online to PeerView.com/VWR860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Due to the rarity of Rett syndrome and overlapping symptoms with other, more common neurodevelopmental disorders, diagnosis is challenging and often missed or delayed. With one Rett-targeted therapy recently approved and others in development, clinicians now have the opportunity to offer not merely symptom management but potential clinical improvement. This PeerView case-based activity is designed to improve your ability to recognize, diagnose, and treat patients with Rett syndrome. Each session features a realistic case discussion with expert faculty panelists sharing the evidence that supports clinical decisions for timely diagnosis and early initiation of multidisciplinary management and targeted therapy as appropriate. Upon completion of this activity, participants should be better able to: Apply diagnostic criteria to provide a timely diagnosis of Rett syndrome in patients demonstrating subtle signs and symptoms; Employ evidence-based, age-appropriate care for patients with Rett syndrome in alignment with consensus management guidelines; and Evaluate the evidence surrounding the safety, efficacy, and tolerability of new and emerging therapies for the treatment of Rett syndrome.

Go online to PeerView.com/VWR860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Due to the rarity of Rett syndrome and overlapping symptoms with other, more common neurodevelopmental disorders, diagnosis is challenging and often missed or delayed. With one Rett-targeted therapy recently approved and others in development, clinicians now have the opportunity to offer not merely symptom management but potential clinical improvement. This PeerView case-based activity is designed to improve your ability to recognize, diagnose, and treat patients with Rett syndrome. Each session features a realistic case discussion with expert faculty panelists sharing the evidence that supports clinical decisions for timely diagnosis and early initiation of multidisciplinary management and targeted therapy as appropriate. Upon completion of this activity, participants should be better able to: Apply diagnostic criteria to provide a timely diagnosis of Rett syndrome in patients demonstrating subtle signs and symptoms; Employ evidence-based, age-appropriate care for patients with Rett syndrome in alignment with consensus management guidelines; and Evaluate the evidence surrounding the safety, efficacy, and tolerability of new and emerging therapies for the treatment of Rett syndrome.

Got patients with extensive skincare routines? They might not be as necessary as they think. This week, we're joined by Dr. Yuval Bibi as he dives into what healthy skin actually needs. Listen in as he discusses "skinese," the reality behind hot water, what irritates the skin, and how cleaning doesn't always mean cleaning. Each Thursday, join Dr. Raja and Dr. Hadar, board-certified dermatologists, as they share the latest evidence-based research in integrative dermatology. For access to CE/CME courses, become a member at LearnSkin.com. Yuval Bibi, MD PhD is a distinguished dermatologist of Israeli origin who currently resides in the United States. He holds certification from the American Board of Dermatology and boasts a diverse range of talents and achievements. Dr. Bibi commenced his academic journey at Ben Gurion University in Beer Sheva, Israel, enrolling in the MD/PhD program. He later ventured to Worcester, Massachusetts, to pursue his research on human papillomavirus related cancer biology and innate immunity at UMass Medical School.   Following his research endeavors, Dr. Bibi embarked on his clinical training as a dermatologist through the combined residency program at Boston University and Tufts University. Boston served as the backdrop for his clinical practice for several years until he made the decision to relocate to Los Angeles, California. The move to California provided him with an opportunity to explore his passion for acting and screenwriting while concurrently nurturing his interest in the realm of minimalistic skincare products. Motivated by this passion, he established his own vegan skincare company, named Dr. Bibi Organics. In early 2021, Dr. Bibi relocated once again, this time to Palm Beach County in South Florida. He continues to serve as a dermatologist in the area, while also actively engaging in various pursuits. These include sharing his knowledge through skincare education, creative writing, expanding his skincare company, and undertaking other ventures. As a clinician, Dr. Bibi possesses particular expertise in scalp dermatology, oral and genital dermatology, as well as nail dermatology, allowing him to provide specialized care to his patients in these areas of focus. Dr. Bibi is the author of “Sick Skin - Skincare Made Simple,” an Amazon bestseller exploring the many fallacies cultivated and abused by the skincare industry, as well as providing a comprehensive skincare guide to understanding the language of one's own skin: “Skinese” and providing for the skin's basic needs in the most cost effective manner.

https://www.paypal.me/Truelifepodcast?locale.x=en_USAlexander Lebedev, MD PhD Entrepreneur | Full-Stack Data Scientist​At the intersection of technology and human resilience, I envision a future where tech is a powerful ally in enhancing our well-being. With an MD/PhD and over 15 years of experience in psychiatry and applied data science, I bridge the gap between the human mind and technological innovation.My life's mission? Crafting sustainable mental health frameworks that seamlessly integrate with the digital age. While I'm deeply committed to leading my own projects and academic research, I also find balance and discipline as a lifelong martial artist – sometimes even skipping lunches for jiu-jitsu rolls.For those looking to harness the power of technology, I offer tailored tech consulting services. Whether you're a budding startup or running an established organisation, with my proven expertise in machine learning and NLP, I'm here to elevate your business in today's digital era. Ready to explore the transformative impact of your projects? Let's talk.https://www.allebedev.com/Contact e-mail:alexander.vl.lebedev@gmail.com​ https://www.paypal.me/Truelifepodcast?locale.x=en_US

In this episode of the Award-winning PRS Journal Club Podcast, 2023 Resident Ambassadors to the PRS Editorial Board – Rami Kantar, Yoshi Toyoda, and Ronnie Shammas- and special guest Rebecca W. Knackstedt, MD, PhD, discuss the following articles from the October 2023 issue: “Air versus Saline in Initial Prepectoral Tissue Expansion: A Comparison of Complications and Perioperative Patient-Reported Outcomes” Plotsker, Coriddi, RRubenstein, et al. Read the article for FREE: https://bit.ly/AirvsSaline Special guest Rebecca W. Knackstedt, MD, PhD, is a reconstructive microsurgeon at Duke University who specializes in breast reconstruction. She completed her residency training in the Cleveland Clinic followed by a microsurgery fellowship at the Cleveland Clinic as well. She's currently an attendee physician of Plastic Surgery at Duke University. READ the articles discussed in this podcast as well as free related content from the archives: https://bit.ly/JCOct23Collection #PRSJournalClub

Get to know Cristy Garza-Mayers, MD, PhD. Dr. Garza-Mayers is an Instructor at Harvard Medical School and a pediatric dermatologist at Mass General Brigham with an interest in vitiligo. In addition to her work on PeDRA's Early Investigator Committee, she also serves as a mentor through the PeDRA Mentorship Program and has received funding for her research projects through two grant programs. Learn more about her research, what led her to pediatric dermatology, and listen to the end to hear her answer some fun, rapid fire questions.

In recent years, a number of new medical schools – both allopathic and osteopathic – have launched and still more are in preparation.   In 2017 Kaiser Permanente announced the appointment of Dr. Mark A. Schuster of Harvard Medical School and Boston Children's Hospital as the founding dean of the Kaiser Permanente Bernard J. Tyson School of Medicine. A renowned figure in pediatric, adolescent, and family health; family leave; obesity prevention; sexual and gender minority health; bullying; and quality of health care, Schuster pledged to build the new school “from the ground up” on evidence-based best practices. Six years later, the Kaiser Permanente Bernard J. Tyson School of Medicine was established.   In this INNOVATORS, Dr. Schuster answers the why, how, and so what of launching a new medical school. INNOVATORS is a podcast production of Harris Search Associates.  *The views and opinions shared by the guests on INNOVATORS do not necessarily reflect the views of the interviewee's institution or organization.*

Dr. Albert Kim is the August A. Busch Jr. Professor of Neurological Surgery, Senior Vice-Chair of the Department of Neurosurgery, and Professor of Genetics, Neurology, and Developmental Biology at Washington University School of Medicine. He is also the inaugural Director of the Washington University Brain Tumor Center and Surgical Director of the Pituitary Center. Dr. Kim is an expert in glioblastoma, the most common and most aggressive primary brain tumor in adults. His laboratory studies the ways that glioblastoma arises as well as ways to treat it through targeting genetics, metabolism, and the immune system in addition to the use of high powered lasers to thermally ablate tumors. As one of the researchers in his lab, I can attest to Dr. Kim's true brilliance as a physician and scientist, so I hope you enjoy this episode. Title music: World Is Holding Hands by WinnieTheMoog https://creativecommons.org/licenses/by/4.0/legalcode Background music: En Plein Air by L'Esprit d'Sfign https://creativecommons.org/licenses/by-nc/4.0/legalcode.en

Inside the Issue: Integrating Targeted and Immunotherapy into the Management of Localized Non-Small Cell Lung Cancer | Faculty Presentation 2: Novel Approaches to Adjuvant Treatment for Localized NSCLC CME information and select publications

I am an emergency physician and a historian. In my clinical work, I am an attending physician at Brigham and Women's Hospital and an Instructor in Emergency Medicine at Harvard Medical School. I received my BA from Harvard University, MD and PhD from the University of Pennsylvania, and completed residency training in emergency medicine at Brown/Rhode Island Hospital.My research focuses on the history and political economy of health care and on diagnostics for emergency care in resource-limited settings. Recently, I have written about international opiate regulations, population control campaigns, feminist critiques of the GDP, and hepatitis C diagnostic technologies. My first book, No More to Spend (Oxford University Press, 2020), is a history of medical neglect and exploitation in Malawi. This book was named a CHOICE Outstanding Academic Title.In my current research, I aim to use machine learning to improve early warning scores and diagnose emergent conditions in settings of clinical impoverishment.I am also writing a history of medical debt collection in the United States. This book, Your Money or Your Life, is under contract with Oxford University Press and scheduled for publication in Fall 2023. It tells the story of how the collection of medical debt in the United States has transformed over the last several decades and how this impacts Americans' lives.   Become a member at https://plus.acast.com/s/unimpressedpodcast. https://plus.acast.com/s/unimpressedpodcast. Hosted on Acast. See acast.com/privacy for more information.

In this episode of the Award-winning PRS Journal Club Podcast, 2023 Resident Ambassadors to the PRS Editorial Board – Rami Kantar, Yoshi Toyoda, and Ronnie Shammas- and special guest Rebecca W. Knackstedt, MD, PhD, discuss the following articles from the October 2023 issue: “A Comparative Study of Wraparound versus Anterior Coverage Placement of Acellular Dermal Matrix in Prepectoral Breast Reconstruction” by Han, Han, Eom, et al. Read the article for FREE: https://bit.ly/WraparoundADM Special guest Rebecca W. Knackstedt, MD, PhD, is a reconstructive microsurgeon at Duke University who specializes in breast reconstruction. She completed her residency training in the Cleveland Clinic followed by a microsurgery fellowship at the Cleveland Clinic as well. She's currently an attendee physician of Plastic Surgery at Duke University. READ the articles discussed in this podcast as well as free related content from the archives: https://bit.ly/JCOct23Collection #PRSJournalClub

Teaching and Learning: Neuroanatomy featuring Maria Peris-Celda, MD, PhD, FAANSDr. Peris Celda is an Associate Professor in neurosurgery who specializes in complex brain and skull base tumors and other neurosurgical cranial conditions. She is devoted to offering individualized treatment to each patient including open, minimally invasive, and endoscopic techniques to maximize surgical resection and achieve surgical goals preserving quality of life.Following her surgical anatomy fellowship under world-renowned neurosurgeon Professor A.L. Rhoton, Dr. Peris Celda's research interests have focused on the development of safer surgical techniques and approaches based on a detailed surgical anatomy knowledge. Dr. Peris Celda's neurosurgical anatomy laboratory team comprises fellows of different backgrounds, national and international, who are deeply committed to surgical education and to advancing surgical techniques towards safer, more accurate surgeries.

Dr. Marie Hollenhorst is an Instructor of Medicine in Hematology at Brigham and Women's Hospital and Harvard Medical School. Dr. Hollenhorst earned her MD and PhD from Harvard University followed by residency in internal medicine at Brigham and Women's Hospital, a fellowship in transfusion medicine at Harvard Medical School, and a fellowship in hematology at Stanford before ultimately joining faculty at Harvard and Brigham and Women's Hospital. Today, Dr. Hollenhorst discusses her training journey, how it can be improved for future generations, and her recent transition to faculty Credits: Our thanks to Dr. Hollenhorst for coming on the show! Twitter/x: @hollenhorstM Faculty page: https://physiciandirectory.brighamandwomens.org/details/16143/marie-hollenhorst-hematology-boston Executive Producers: -       Bejan Saeedi -       Joe Behnke -       Michael Sayegh -       Carey Jansen -       Nielsen Weng Faculty Advisors  -       Brian Robinson -       Mary Horton -       Talia Swartz -       Chris Williams -       David Schwartz Twitter: @behindthescope_ Instagram: @behindthemicroscopepod Facebook: @behindthemicroscope1 Website: behindthemicroscope.com

In this episode of the Award-winning PRS Journal Club Podcast, 2023 Resident Ambassadors to the PRS Editorial Board – Rami Kantar, Yoshi Toyoda, and Ronnie Shammas- and special guest Rebecca W. Knackstedt, MD, PhD, discuss the following articles from the October 2023 issue: “Topical Tranexamic Acid in Breast Reconstruction: A Double-Blind Randomized Controlled Trial” by Safran, Vorstenbosch, Viezel-Mathieu, et al. Read the article for FREE: https://bit.ly/TopicalTXA Special guest Rebecca W. Knackstedt, MD, PhD, is a reconstructive microsurgeon at Duke University who specializes in breast reconstruction. She completed her residency training in the Cleveland Clinic followed by a microsurgery fellowship at the Cleveland Clinic as well. She's currently an attendee physician of Plastic Surgery at Duke University. READ the articles discussed in this podcast as well as free related content from the archives: https://bit.ly/JCOct23Collection #PRSJournalClub

Both long-term alcohol consumption and binge drinking can speed up biological aging, according to a Northwestern Medicine study published in the journal Aging. Lifang Hou, MD, PhD, chief of Cancer Epidemiology and Prevention in the Department of Preventive Medicine led the study and discusses the link between genetics and lifestyle in the context of preventing disease.  

In this episode, host Ben Fraser is joined by Dr. Christopher Loo, founder, CEO and host of Financial Freedom for Physicians with Dr. Christopher H. Loo, MD-PhD podcast. Dr. Loo shares his inspiring journey from being an MD to achieving financial freedom through real estate investing. We delve into his personal story, exploring how he transitioned from a medical career to early retirement and financial independence through strategic investments. Dr. Loo provides insights into his current investment portfolio, identifies potential opportunities, and sheds light on the mindsets that have propelled him to his current success. Tune in to be inspired by Dr. Christopher Loo's path to financial freedom. Connect with Dr. Christopher Loo on LinkedIn https://www.linkedin.com/in/drchrisloomdphd/⁠ Connect with Ben Fraser on LinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/benwfraser/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠   Invest Like a Billionaire podcast is sponsored by Aspen Funds which focuses on macro-driven alternative investments for accredited investors. Get started and download your free economic report today at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://aspenfunds.us/report⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠  Join the Investor Club to get early access to exclusive deals. ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.aspenfunds.us/investorclub⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠  Subscribe on your favorite podcast app, so you never miss an episode. ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.thebillionairepodcast.com/subscribe

I decided to encore this episode with Carly Eckert, MD, PhD(c), MPH, because I keep finding myself quoting Dr. Eckert in conversations, even a year later. First off, if you're not familiar, a care gap is what happens when there is a bad transition of care. Patient has no idea what their discharge instructions actually mean, so they wind up back in the hospital. Patient didn't pick up their prescription, so they wind up in the hospital or back in the hospital. Patient still has uncontrolled hypertension long after being diagnosed with uncontrolled hypertension or uncontrolled diabetes. It's crazy how many patients keep going to their doctor and being told they have high blood pressure or high blood sugar and their care plans are not adjusted. Or they don't take their meds due to cost or a lack of trust or whatever other reason. Or care gaps exist because the patients don't go to their doctor in the first place. So, they settle right into a care gap that no doctor can fix because down there in the bottom of that care gap, there's no medical professionals. So, a year later and the year after that, their blood sugar or their blood pressure is still high. These are patients in care gaps. I mean, consider that heart failure … I heard it called the “a little too late disease” by William Bestermann, MD, the other day. You don't just spontaneously develop heart failure, after all. If you have uncontrolled hypertension and/or uncontrolled diabetes for too long, you will get heart failure and you'll also probably get chronic kidney disease. Chronic kidney disease, by the way, is often the cause of most heart failure readmissions, so think about the entire impact of heart failure and most kidney disease when you think about the cost of care gaps. This is what we talk about today. And with that, here's your encore. In this healthcare podcast, I'm speaking with Carly Eckert, MD. It's kinda funny, actually. I originally wanted to get Dr. Eckert on the show to talk about care gaps and how to close them, but this show did not wind up going how I thought it was going to go because Carly Eckert is a physician by training who got really interested in the upstream causes of what she was seeing in clinical practice. Despite my best efforts, she refused to be lured into my closing care gaps conversation. So, instead, this conversation is about the construct of care gaps and thinking about them in context. Closing care gaps is a model of care and maybe not a particularly great one, relatively speaking. In fact, here's another name for the model of care called closing care gaps: care gap whack-a-mole. Care gap pops up … we whack it. Care gap pops up … we try to close it. Another care gap pops up … we try to close it. Another care gap … you get the idea. Carly Eckert has worked in epidemiology and public health and also clinical informatics for health systems and payers. I recorded this show with Dr. Eckert prior to EP359 with Dan O'Neill. In that interview, which you should go back and listen to when you have a sec, Dan O'Neill cleared up a couple of things that I struggled with during this interview. Here's the big one that I could not figure out: Why with the whack-a-mole? Why do we still insist as a nation on waiting for someone to show up in clinic to retroactively and reactively address a missed preventative care opportunity? Why don't so many more provider organizations create pop health programs that consider the whole person proactively? Why don't they take the time to operationalize whole-person care in a meaningful way? Ah, yes … to the surprise of exactly no one, it's all about the Benjamins. As Dan O'Neill put it, if all a provider organization is doing is slapping a sheet on a doc's desk every morning with a list of care gaps for all the patients that he/she will see that day, it's highly likely that incentives, or penalties to do anything else, are very weak. It's a sign that, from a paying for value perspective, we're not paying enough for value that it's worth it or maybe even feasible for any provider organization to take the time and capital expense to switch up their business model in any meaningful way. So, the provider gets a little bump or a little knock if they don't meet some quality standard. Okay, great … so then they'll minimally tweak their workflow and have doctors within their 7- to 15-minute visit suss out and try to close care gaps. I don't want to say this is entirely negative. It's known that when provider organizations do close care gaps, patient outcomes do tend to get better—so, not arguing that. But there's opportunities that get left on the table with all this reactiveness. Bottom line: You insurers, you purchasers of healthcare, pay for value, for real. But you provider organizations, if you don't fix this stuff yourself, you're gonna get doctors and other clinicians (as we're seeing) burning out and quitting because there's only so much you can jam into a 7- or 15-minute visit, number one. But number two, doing population health reactively like this is suboptimal—and everybody knows it. So, what winds up happening is dedicated doctors and nurses desperately want to do the right thing but simply do not have the time. And they watch patient after patient suffer for it. That sucks. So, fix it. At the end of the day, it's probably cheaper than having to recruit all new doctors and hire traveling nurses when all of the current staff quits due to burnout and/or moral injury.   You can learn more by connecting with Dr. Eckert on LinkedIn and following her on X (Twitter).     Carly Eckert, MD, PhD(c), MPH, is a physician and technologist with dual board certifications in preventive medicine and clinical informatics. With nearly a decade of experience, Dr. Eckert has led multidisciplinary teams encompassing clinical, product development, and data science domains within healthcare start-ups. Her areas of expertise include AI governance, ethical considerations, and bias mitigation, along with a deep understanding of healthcare data and its appropriate use. Dr. Eckert also educates fellow physicians and healthcare professionals on the practical and applied facets of AI solutions, as well as how to foster effective communication with technical teams. In her current professional role, Dr. Eckert is embarking on collaborations with various partners to assess and accelerate the transformative influence of data and technology on care delivery. The overarching goal of this work is to enhance the healthcare experience for broad and varied populations, with exciting new developments on the horizon.   05:31 What is the true goal in making population health successful? 05:58 How does the clinical pathway need to manifest in population health? 06:29 How do we get a nonfragmented state of care? 06:54 What is the best model of care? 08:37 “Identifying and addressing care gaps is an important element of population health.” 11:30 Closing care gaps vs creating a nonfragmented system of care. 15:38 “I think you have to take small steps with people.” 16:45 “There's a lot of power in peer support.” 17:18 Why should provider organizations connect with peer groups? 19:05 “The key is that it's not going to be the same for everybody.” 23:09 Why is diversity of the workforce key to closing care gaps? 23:33 EP322 with Monica Lypson, MD, MHPE. 23:37 EP347 with Ian Tong, MD. 28:36 Where can providers improve transparency to help close care gaps?   You can learn more by connecting with Dr. Eckert on LinkedIn and following her on X (Twitter).   @carlymeckert discusses #caregaps in #healthcare on our #healthcarepodcast. #podcast #digitalhealth #valuebasedcare #vbc   Recent past interviews: Click a guest's name for their latest RHV episode! Dr Robert Pearl, Larry Bauer (Summer Shorts 8), Secretary Dr David Shulkin and Erin Mistry, Keith Passwater and JR Clark (Summer Shorts 7), Lauren Vela (Summer Shorts 6), Dr Jacob Asher (Summer Shorts 5), Eric Gallagher (Summer Shorts 4), Dan Serrano, Larry Bauer, Dr Vivek Garg (Summer Shorts 3)